Ads
related to: darzalex- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- About DARZALEX®
Learn About a Treatment Method and
How DARZALEX® Works
- Important Safety Info
Learn About Important Safety
Information for DARZALEX®
- Read Patient Stories
Learn About the Treatment Journey
From Real Patients & Caregivers
- Questions for Your Doctor
Find a List Of Questions for You to
Ask Your Healthcare Provider
- For Caregivers
Learn More About How You Can Help
Your Loved One Throughout Treatment
- DARZALEX® Side Effects
Search results
Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters via AOL· 10 months agoInjectable versions of some widely-used cancer drugs including Johnson & Johnson's blockbuster...
J&J's (JNJ) Q4 Earnings Beat, Darzalex, Stelara Drive Sales
Zacks via Yahoo Finance· 4 months agoJohnson & Johnson’s JNJ fourth-quarter 2023 earnings came in at $2.29 per share, which beat the...
Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme
Investor's Business Daily· 1 year agoConfusion over new Medicare negotiating plans sent Regeneron Pharmaceuticals and Halozyme...
Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates
Zacks via Yahoo Finance· 3 weeks agoHalozyme Therapeutics, Inc. HALO reported first-quarter 2024 adjusted earnings of 79 cents per...
Halozyme (HALO) Q4 Earnings Top, Revenues Miss, Stock Down
Zacks via Yahoo Finance· 1 year agoHalozyme Therapeutics, Inc. HALO reported fourth-quarter 2022 adjusted earnings of 48 cents per...
Halozyme (HALO) Q1 Earnings Disappoint, Revenues Rise Y/Y
Zacks via Yahoo Finance· 1 year agoHalozyme Therapeutics, Inc. HALO reported first-quarter 2023 adjusted earnings of 47 cents per...
Strong Q2 at J&J, but outlook cut again due to dollar's rise
Associated Press via Yahoo News· 2 years agoJohnson & Johnson rode sales of the cancer treatment Darzalex and other key drugs to a...
Here's The Surprising Driver Of J&J's Second-Quarter Beat, And Why It Didn't Help
Investor's Business Daily· 2 years agoHealth care bellwether Johnson & Johnson topped second-quarter expectations Tuesday, but JNJ stock...
Will J&J (JNJ) Pharma Unit Outperform Market & Drive Q1 Results?
Zacks via Yahoo Finance· 1 year agoIn J&J's (JNJ) Pharma segment, its oncology drug, Darzalex as well as a psoriasis treatment, Stelara...
Genmab: Growth Is Still a Better Choice
GuruFocus.com via Yahoo Finance· 3 months agoGenmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple...
Ads
related to: darzalex